Free Trial

UBS Group (UBS) SEC Filings & 10K Form

UBS Group logo
$35.72 -0.39 (-1.08%)
Closing price 07/11/2025 03:59 PM Eastern
Extended Trading
$35.80 +0.08 (+0.22%)
As of 07/11/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent UBS Group SEC Filings

DateFilerForm TypeView
06/26/2025
1:23 PM
UBS Group (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/26/2025
1:29 PM
UBS Group (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/06/2025
11:15 AM
UBS AG (Filer)
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/06/2025
11:26 AM
UBS AG (Filer)
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/13/2025
3:20 PM
UBS Group (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
05/08/2025
5:30 AM
UBS AG (Filer)
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/08/2025
5:28 AM
UBS AG (Filer)
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/05/2025
1:56 PM
UBS AG (Filer)
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/01/2025
5:24 AM
Rapid7, Inc. (Subject)
UBS Group (Filed by)
Form SCHEDULE 13G/A
04/30/2025
3:41 PM
Renalytix plc (Subject)
UBS Group (Filed by)
Form SCHEDULE 13G/A
04/30/2025
3:15 PM
Renalytix plc (Subject)
UBS Group (Filed by)
Form SCHEDULE 13G/A
04/30/2025
2:31 PM
UBS Group (Filed by)
Western Asset Investment Grade Opportunity Trust Inc. (Subject)
Form SCHEDULE 13G
04/30/2025
2:48 PM
Color Star Technology Co., Ltd. (Subject)
Color Star Technology Co., Ltd. (Subject)
UBS Group (Filed by)
Form SCHEDULE 13G/A
04/30/2025
10:44 AM
Infinera Corp (Subject)
UBS Group (Filed by)
Form SCHEDULE 13G/A
04/30/2025
5:31 AM
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2025
5:33 AM
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2025
5:20 AM
UBS AG (Filer)
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2025
5:27 AM
UBS AG (Filer)
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/25/2025
1:33 PM
CLOROX CO /DE/ (Subject)
UBS Group (Filed by)
Form SCHEDULE 13G/A
04/25/2025
10:41 AM
CLOROX CO /DE/ (Subject)
UBS Group (Filed by)
Form SCHEDULE 13G
04/17/2025
12:04 PM
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/14/2025
2:40 PM
NORGES BANK (Filed by)
UBS Group (Subject)
Form SCHEDULE 13G/A
03/17/2025
7:35 AM
UBS AG (Filer)
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/17/2025
7:24 AM
UBS AG (Filer)
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/17/2025
7:25 AM
UBS AG (Filer)
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/17/2025
7:26 AM
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/17/2025
7:27 AM
UBS Group (Filer)
Form IRANNOTICE
03/17/2025
6:51 AM
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/17/2025
6:56 AM
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/17/2025
6:41 AM
UBS Group (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/04/2025
5:07 AM
UBS AG (Filer)
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/25/2025
4:14 PM
Global Star Acquisition Inc. (Issuer)
Global Star Acquisition Inc. (Issuer)
Global Star Acquisition Inc. (Issuer)
Global Star Acquisition Inc. (Issuer)
UBS Group (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
8:49 AM
UBS Group (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
02/10/2025
9:59 AM
UBS Group (Filed by)
Vipshop Holdings Ltd (Subject)
Form SCHEDULE 13G/A
02/10/2025
9:42 AM
PIMCO Access Income Fund (Subject)
UBS Group (Filed by)
Form SCHEDULE 13G/A
02/10/2025
8:26 AM
Renalytix plc (Subject)
UBS Group (Filed by)
Form SCHEDULE 13G
02/10/2025
7:59 AM
Amneal Pharmaceuticals, Inc. (Subject)
UBS Group (Filed by)
Form SCHEDULE 13G/A
02/10/2025
8:13 AM
Liberty Broadband Corp (Subject)
Liberty Broadband Corp (Subject)
Liberty Broadband Corp (Subject)
UBS Group (Filed by)
Form SCHEDULE 13G/A
02/10/2025
7:33 AM
Color Star Technology Co., Ltd. (Subject)
Color Star Technology Co., Ltd. (Subject)
UBS Group (Filed by)
Form SCHEDULE 13G
02/05/2025
12:24 PM
UBS AG (Filer)
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/04/2025
8:32 AM
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Google did what!?!? (Ad)

A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.

Gates and Altman are betting big—see why
02/04/2025
6:22 AM
UBS AG (Filer)
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/04/2025
6:26 AM
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
9:01 AM
UBS Group (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
11/08/2024
11:14 AM
NORGES BANK (Filed by)
UBS Group (Subject)
Form SC 13G
11/08/2024
5:23 AM
UBS AG (Filer)
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/08/2024
5:26 AM
UBS AG (Filer)
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/06/2024
11:04 AM
Infinera Corp (Subject)
UBS Group (Filed by)
Form SCHEDULE 13G
11/04/2024
9:49 AM
Rapid7, Inc. (Subject)
UBS Group (Filed by)
Form SCHEDULE 13G
11/01/2024
8:00 AM
abrdn Income Credit Strategies Fund (Subject)
UBS Group (Filed by)
Form SCHEDULE 13G/A
11/01/2024
6:13 AM
UBS AG (Filer)
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/01/2024
5:47 AM
UBS AG (Filer)
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/31/2024
9:43 AM
Thornburg Income Builder Opportunities Trust (Subject)
UBS Group (Filed by)
Form SCHEDULE 13G
10/30/2024
2:18 PM
Cohen & Steers Ltd Duration Preferred & Income Fund, Inc. (Subject)
UBS Group (Filed by)
Form SCHEDULE 13G/A
10/30/2024
10:30 AM
Liberty Broadband Corp (Subject)
Liberty Broadband Corp (Subject)
Liberty Broadband Corp (Subject)
UBS Group (Filed by)
Form SCHEDULE 13G
10/30/2024
10:04 AM
Amneal Pharmaceuticals, Inc. (Subject)
UBS Group (Filed by)
Form SCHEDULE 13G
10/30/2024
5:39 AM
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/30/2024
5:27 AM
UBS AG (Filer)
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/30/2024
5:31 AM
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/30/2024
5:34 AM
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/11/2024
8:42 AM
UBS AG (Filer)
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/11/2024
8:44 AM
UBS AG (Filer)
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/05/2024
2:28 PM
ENDRA Life Sciences Inc. (Issuer)
ENDRA Life Sciences Inc. (Issuer)
ENDRA Life Sciences Inc. (Issuer)
UBS Group (Reporting)
Form 4/A
09/05/2024
1:47 PM
ENDRA Life Sciences Inc. (Issuer)
ENDRA Life Sciences Inc. (Issuer)
ENDRA Life Sciences Inc. (Issuer)
UBS Group (Reporting)
Form 3/A
09/03/2024
2:25 PM
UBS Group (Filer)
Form N-PX
Annual Report of Proxy Voting Record of Registered Management Investment Company  
08/29/2024
3:30 PM
ENDRA Life Sciences Inc. (Issuer)
ENDRA Life Sciences Inc. (Issuer)
ENDRA Life Sciences Inc. (Issuer)
UBS Group (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
11:11 AM
ENDRA Life Sciences Inc. (Issuer)
ENDRA Life Sciences Inc. (Issuer)
ENDRA Life Sciences Inc. (Issuer)
UBS Group (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/23/2024
7:33 AM
UBS AG (Filer)
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/23/2024
7:37 AM
UBS AG (Filer)
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/23/2024
7:27 AM
UBS AG (Filer)
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/23/2024
7:31 AM
UBS AG (Filer)
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2024
9:29 AM
UBS AG (Filer)
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2024
6:24 AM
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2024
6:29 AM
UBS AG (Filer)
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2024
6:22 AM
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2024
6:09 AM
UBS AG (Filer)
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2024
6:12 AM
UBS AG (Filer)
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2024
6:19 AM
UBS AG (Filer)
UBS Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/08/2024
11:55 AM
Sight Sciences, Inc. (Subject)
UBS Group (Filed by)
Form SCHEDULE 13G/A
08/08/2024
11:48 AM
MARCUS CORP (Subject)
UBS Group (Filed by)
Form SCHEDULE 13G/A
08/08/2024
10:36 AM
ASLAN Pharmaceuticals Ltd (Subject)
UBS Group (Filed by)
Form SCHEDULE 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:UBS) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners